idiopathic Parkinson's disease
Thirteen patients with idiopathic Parkinson's disease and "on-off" fluctuations on oral levodopa plus dopa decarboxylase inhibitor (DDI) were treated with continuous (24 hour) subcutaneous lisuride infusions together with a reduced dose of levodopa (plus DDI).
Thirteen patients with <span class="disease" id="2969953-1-23-53">idiopathic Parkinson's disease</span> and "on-off" fluctuations on oral levodopa plus <span class="gene" id="2969953-1-102-120">dopa decarboxylase</span> inhibitor (DDI) were treated with continuous (24 hour) subcutaneous lisuride infusions together with a reduced dose of levodopa (plus DDI).